drugset / Trial / NCT06098209
Dexmedetomidine and Propofol in Mechanically Ventilated Patients by Using Salivary Alpha-amylase as a Stress Marker
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to compare the efficacy of dexmedetomidine and propofol on decreasing stress in mechanically ventilated patients by using salivary alpha-amylase as a stress marker.
Timeline
- Start
- 2023-10-24
- Primary completion
- 2024-04-11
- Completion
- 2024-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 1.4 ug/kg | Intravenous |
| Subject | Propofol | Small molecule | 0.3 mg/kg | Intravenous |
| Subject | Propofol | Small molecule | 4 mg/kg | Intravenous |
Indications
No indication recorded.